Financials

  • Market Capitalization 380.11 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.14
市销率
26.03

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3109
AUTL
Autolus Therapeutics plc - American Depositary Shares
1.43 USD-3.38%-10.63%-11.73%-46.24%380.60 M USD
3121
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.73 USD0.00%+13.37%+6.27%+6.27%387.48 M USD
3133
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.77 USD+0.63%+0.85%+6.95%+48.60%381.73 M USD
3147
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.71 USD-0.37%+0.66%+18.34%+21.02%372.03 M USD

新闻